Skip to main content
. 2021 Oct 20;14(3):144–148. doi: 10.4103/ojo.ojo_18_21

Table 4.

Distribution of visual acuity in therapeutic grafts

BCVA Pre-TPK (n=26), n (%) Last follow up 12 months post-TPK (n=26), n (%)
>20/60 0 2 (7.69)
20/60-20/200 0 8 (30.76)
20/200-20/400 0 2 (7.69)
<20/400 26 (100) 14 (53.84)

BCVA: Best corrected visual acuity, TPK: Therapeutic penetrating keratoplasty